Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

Abstract Introduction Ubiquitin-specific peptidase 22 (USP22) is described as a stem cell (CSC) marker which is involved in many biological processes, including cancer development, cellular growth and differentiation. Sirtuin 1 (SIRT1) controls a set of biologic processes that range from metabolic h...

Full description

Bibliographic Details
Main Authors: Ola A. Harb, Randa Mohamed Kaf, Heba F. Taha, Safa A. Balata, Rehab Hemeda, Ahmed Mohamed Yehia, Loay M. Gertallah, Ahmed Embaby
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Surgical and Experimental Pathology
Subjects:
Papillary-thyroid-carcinoma
USP22
SIRT1
E-cadherin
Immunohistochemistry
Prognosis
Online Access:http://link.springer.com/article/10.1186/s42047-019-0048-5

Internet

http://link.springer.com/article/10.1186/s42047-019-0048-5

Similar Items